Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.

Laletin, Vladimir; Bernard, Pierre-Louis; Costa da Silva, Cathy; Guittard, Geoffrey; Nunes, Jacques A

Laletin, Vladimir; Bernard, Pierre-Louis; Costa da Silva, Cathy; Guittard, Geoffrey; Nunes, Jacques A.

Afiliación

Laletin V; Immunity and Cancer, Cancer Research Centre Marseille, Marseille, France.
Bernard PL; Onco-hematology and immuno-oncology (OHIO), Centre de Recherche en Cancérologie de Marseille, Marseille, France.
Costa da Silva C; Immunity and Cancer, Cancer Research Centre Marseille, Marseille, France.
Guittard G; Onco-hematology and immuno-oncology (OHIO), Centre de Recherche en Cancérologie de Marseille, Marseille, France.
Nunes JA; Immunity and Cancer, Cancer Research Centre Marseille, Marseille, France.

J Immunother Cancer ; 11(5)2023 05.

Article en En | MEDLINE | ID: mdl-37217244

Asunto(s)

Inmunoterapia; Neoplasias; Humanos; Neoplasias/terapia; Neoplasias/metabolismo; Linfocitos T

Palabras clave

Immune Checkpoint Inhibitors; Immunotherapy; Lymphocyte Activation; Receptors, Antigen; T-Lymphocytes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article